128 related articles for article (PubMed ID: 8352566)
21. [From the research laboratory to the clinical laboratory: reflections on the transfer of technology about drug resistance].
Favre R
Bull Cancer; 1994 Dec; 81 Suppl 2():112s-114s. PubMed ID: 7727856
[TBL] [Abstract][Full Text] [Related]
22. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
[TBL] [Abstract][Full Text] [Related]
23. Drug resistance in cancer therapy.
Cancer Treat Res; 1989; 48():1-203. PubMed ID: 2577132
[No Abstract] [Full Text] [Related]
24. Multidrug resistance in cancer therapy: role of the microenvironment.
Galmarini CM; Galmarini FC
Curr Opin Investig Drugs; 2003 Dec; 4(12):1416-21. PubMed ID: 14763126
[TBL] [Abstract][Full Text] [Related]
25. [Novel targets for cancer chemotherapy].
Inoue S
Gan To Kagaku Ryoho; 1996 Jan; 23(2):191-201. PubMed ID: 8611047
[TBL] [Abstract][Full Text] [Related]
26. Resistance to chemotherapy in cancer: a complex and integrated cellular response.
Mellor HR; Callaghan R
Pharmacology; 2008; 81(4):275-300. PubMed ID: 18259091
[TBL] [Abstract][Full Text] [Related]
27. Three important new therapeutic strategies for patients with cancer.
Green MR
Med Times; 1979 May; 107(5):101-5. PubMed ID: 449638
[No Abstract] [Full Text] [Related]
28. New test reveals extreme drug resistance in many cancer patients.
Oncology (Williston Park); 1990 May; 4(5):76. PubMed ID: 2143412
[No Abstract] [Full Text] [Related]
29. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
[TBL] [Abstract][Full Text] [Related]
30. Overcoming drug resistance in the treatment of cancer.
Am Pharm; 1984 Apr; NS24(4):12-4. PubMed ID: 6720567
[No Abstract] [Full Text] [Related]
31. Drug resistance in chemotherapy for breast cancer.
Saeki T; Tsuruo T; Sato W; Nishikawsa K
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of resistance to chemotherapy in the therapeutic strategy for cancer].
Droz JP
Bull Cancer; 1994 Dec; 81 Suppl 2():91s-94s. PubMed ID: 7727869
[No Abstract] [Full Text] [Related]
33. Transcription factors and drug resistance.
Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
[TBL] [Abstract][Full Text] [Related]
34. Targeting senescence pathways to reverse drug resistance in cancer.
Rebbaa A
Cancer Lett; 2005 Feb; 219(1):1-13. PubMed ID: 15694659
[TBL] [Abstract][Full Text] [Related]
35. Clinical problems of resistance to cancer chemotherapeutic agents.
Lane M
Fed Proc; 1979 Jan; 38(1):103-7. PubMed ID: 759229
[No Abstract] [Full Text] [Related]
36. Molecular biology of multidrug resistance in human cells.
Pastan IH; Gottesman MM
Important Adv Oncol; 1988; ():3-16. PubMed ID: 3042608
[No Abstract] [Full Text] [Related]
37. Qualitative and quantitative in vitro sensitivity tests for cancer chemotherapy.
Knock FE
Natl Cancer Inst Monogr; 1971 Dec; 34():247-50. PubMed ID: 5140870
[No Abstract] [Full Text] [Related]
38. Reversal of multidrug resistance to cancer chemotherapy.
Leyland-Jones B; Dalton W; Fisher GA; Sikic BI
Cancer; 1993 Dec; 72(11 Suppl):3484-8. PubMed ID: 8242580
[TBL] [Abstract][Full Text] [Related]
39. [Individualized drug therapy of cancer based on an in vitro test].
Tveit KM
Tidsskr Nor Laegeforen; 1983 Jan; 103(2):113-6. PubMed ID: 6845299
[No Abstract] [Full Text] [Related]
40. [Aimed chemotherapy of malignancies].
Andrysek O
Cas Lek Cesk; 1974 Jul; 113(28):850-3. PubMed ID: 4848005
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
